C19orf33 and acute myeloid leukemia: The genes (i.e., metallothionein gene family, C19orf33, ELF3, GRB7, IL18, NRN1, and RBM47) in the identified differentially regulated gene networks can be considered as key markers to understand the mechanisms involving drug resistance of azacitidine and AML.